Abstract:Development of dry powder aerosol delivery system involves powder production, formulation, dispersion, delivery, and deposition of the powder aerosol in the airways. Insufficiency of conventional powder production by crystallization and milling has led to development of alternative techniques. Over the last decade, performance of powder formulations has been improved significantly through the use of engineered drug particles and excipient systems which are (i) of low aerodynamic diameters (being porous or of low particle density), and/or (ii) less cohesive and adhesive (via corrugated surfaces, low bulk density, reduced surface energy and particle interaction, hydrophobic additives, and fine carrier particles). Early insights into particle forces and surface energy that help explain the improvement have been provided by analytical techniques such as the atomic force microscopy (AFM) and inverse gas chromatography (IGC). Relative humidity is critical to the performance of dry powder inhaler (DPI) products via capillary force and electrostatic interaction. Electrostatic charge of different particle size fractions of an aerosol can now be measured using a modified electrical low-pressure impactor (ELPI). Compared with powders, much less work has been done on the inhaler devices at the fundamental level. Most recently, computational fluid dynamics has been applied to understand how the inhaler design (such as mouthpiece, grid structure, air inlet) affects powder dispersion. The USP throat is known to under-represent the oropharyngeal deposition of DPI aerosols. Studies using magnetic resonance imaging (MRI) model casts have been undertaken to explain the inter- and intra- subject variation in oropharyngeal deposition. Most of the lung deposition studies performed on commercial products did not allow a thorough understanding of the determinants affecting in vivo lung deposition. A more systematic approach would be necessary to build a useful database on the dependence of lung deposition on the breathing parameters, inhaler design, and powder formulation properties.

The electrospray and its application to targeted drug inhalation

Stable Single Device Multi-Pore Electrospraying of Polymeric Microparticles Via Controlled Electrostatic Interactions

Electrospray application to powder production and surface coating

Review on electrospray nanoparticles for drug delivery: Exploring applications

In-flight electro-neutralisation electrospray for pulmonary drug delivery

Spraying mode effect on droplet formation and ion chemistry in electrosprays

Mechanisms of electrospray jet formation and atomized droplet motion in pulsed-jet mode

Electrostatics of pharmaceutical inhalation aerosols

Effects of different mesh nebulizer sources on the dispersion of powder formulations produced with a new small-particle spray dryer

Dry Powder Aerosol Delivery Systems: Current and Future Research Directions

The structure of electrospray beams in vacuum

Spray characteristics from nasal spray atomization

Electrospray propulsion: Modeling of the beams of droplets and ions of highly conducting propellants

Surface tension effects on immersed electrosprays

Reaction Acceleration in Electrospray Droplets: Size, Distance, and Surfactant Effects

Targeted Drug Delivery to Upper Airways Using a Pulsed Aerosol Bolus and Inhaled Volume Tracking Method

A Simplified Electrospray Ionization Source Based On Electrostatic Field Induction For Mass Spectrometric Analysis Of Droplet Samples

Design and Characterization of a Melt Electrostatic Precipitator for Advanced Drug Formulations

Calculating minimum droplet diameter in dripping, spindle, and cone-jet modes based on experimental data in the electrospray process

A path forward in the development of new aerosol drug delivery devices for pediatrics

Tailoring Dry Microparticles for Pulmonary Drug Delivery: Ultrasonic Spray Freeze-Drying with Mannitol and Salbutamol Sulphate